Thanks Toinv, and I agree with the sentiments. Why are we here? Because we all invested in this promising technology, and want to learn as much as we can, and gain other perspectives as we wait for progress. 

If Eastern's resting place and backstop are at $2.67 (ish?), and they are taken care of no matter what, and I am handled the same way, then I guess I can live with that as worst case. Of course, hopeful for much better, still.

But, what actually happens if RVX defaults, and has to hand over the IP to a foreign entity who are also stakeholders? RVX loses ownership of its premium and defining assets, right? What is RVX stock worth if RVX no longer owns its yet to be developed IP, and I don't own Hepa stock where it could be going, potentially?

Maybe in the May "worst" case, DM has to come out of pocket to preserve the status quo if nothing better has happened by then? ... transfer some wealth from his investments back into his RVX investment so to speak. If, there is no other financier to refinance the debenture and take their turn holding the IP in hoc, in the potential absence of Covid or other clinical/financial success in the meantime. Or, maybe, the nice gentlemen at Hepa/Ori are in it for the long run as partners and just roll the obligation another way.

I realize this is an exercise in "what if" ... but it is a real possibility. 

And/But ... in the end, maybe it will all be worth the wait, who knows.